For research use only. We do not sell to patients.
| Name | Enasidenib | 
|---|---|
| Iupac Chemical Name | 2-methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol | 
| Synonyms | AG-221 | 
| Molecular Formula | C19H17F6N7O | 
| Molecular Weight | 473.38 | 
| Smile | CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1 | 
| InChiKey | DYLUUSLLRIQKOE-UHFFFAOYSA-N | 
| InChi | InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32) | 
| CAS Number | 1446502-11-9 | 
| Related CAS | 
| Packaging | Price | Availability | Purity | Shipping Time | 
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry | 
| Formulation | Solid powder | 
|---|---|
| Purity | 98% | 
| Storage | -20 ºC for 3 years | 
| Solubility | Soluble in DMSO | 
| Handling | |
| Shipping Condition | Shipped under ambient temperature | 
| HS Code | 
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | 
